欣天科技(300615.SZ)公告称，持股9.15%的股东薛枫因个人资金需要，计划在未来3个月内，以集中竞 价或大宗交易方式合计减持公司股份不超过5,804,076股，占公司总股本的3%。减持期间为2025年5月27 日至8月26日。 ...

尽管减持新规已经相当严格，但在实际执行过程中，仍存在一些情况使得减持行为对市场造成较大压力。一方面，在某些特殊情况下，股东仍能找到减持 的途径。比如，虽然规定了控股股东、实际控制人在破发、破净、分红不达标等情形下不得通过集中竞价交易或者大宗交易减持股份，但对于一些非控股 股东、持股比例较小的股东，限制相对较弱。他们可能会在市场波动时，大量减持股份，对股价造成冲击。 多年来上证指数始终难以实现实质性的突破，构建起持续向上的牛市行情。在这一现象背后，隐藏着诸多复杂且深层次的因素，其中股东减持问题显得尤 为突出，即便在减持新规发布后，依然存在一些值得关注的情况。 过去，减持制度存在诸多漏洞，使得部分股东有机会"钻空子"，实现无限减持。例如，在早期，对于股东减持的限制较少，无论是减持的时间、数量还是 信息披露等方面，都缺乏严格的规范。这就导致一些股东，尤其是原始股东，他们的持股成本极低，在公司上市后，随时可以减持套现，获取巨额财富。 即便后来出台了一些规定，如大股东减持需提前披露等，但由于规则不够细化，仍无法有效遏制不合理的减持行为。 2024年5月24日晚间，证监会正式发布《上市公司股东减持股份管理暂行办法》及相关 ...

1. 阿莱德（301419.SZ）：股东吴靖计划15个交易日后3个月内，通过集中竞价和/或大宗交易减持不超 过1.50%的公司股份。 2. 大位科技（600589.SH）：股东高大鹏计划15个交易日后3个月内，通过集中竞价及大宗交易减持不 超过3%的公司股份。 4. 东方创业（600278.SH）：副总经理蒋远扬女士已通过集中竞价方式完成减持8,300股，占公司总股本 0.0009%。 5. 海泰科（301022.SZ）：股东新麟三期通过集中竞价减持524,800股，占公司总股本0.6192%，减持计 划时间已届满。 6. 航天软件（688562.SH）：股东宁波星东计划通过集中竞价减持不超过1.00%的公司股份。 7. 红墙股份（002809.SZ）：股东广东省科技创业投资有限公司、何元杰女士及韩强先生减持计划实施 完毕，分别减持1%、0.132%及0.021%的公司股份。 8. 华昌达（300278.SZ）：股东深圳塔桥投资合伙企业（有限合伙）计划15个交易日后3个月内，通过集 中竞价减持不超过0.703%的公司股份。 9. 华胜天成（600410.SH）：多位董监高计划15个交易日后3个月内，通过集中竞 ...

Core Viewpoint - Qilu Bank is experiencing steady growth in asset scale, profitability, and asset quality, outperforming industry averages, but faces challenges such as declining growth rates and regulatory penalties [2][3][5]. Financial Performance - In 2024, Qilu Bank achieved operating income of 12.496 billion yuan, a year-on-year increase of 4.55%, and net profit attributable to shareholders of 4.986 billion yuan, up 17.77% [2][3]. - Revenue growth has slowed for three consecutive years, with growth rates of 28.11%, 8.82%, 8.03%, and 4.55% from 2021 to 2024 [3]. - Interest income remains the primary source of revenue, contributing 9.031 billion yuan in 2024, a 1.73% increase, while non-interest income, particularly from investment gains, has become a significant growth driver [3][5]. Asset Quality - Qilu Bank's non-performing loan (NPL) ratio improved to 1.19% by the end of 2024, down 0.07 percentage points from the previous year, while the coverage ratio increased to 322.38% [5][6]. - The bank's corporate loans grew by 15.51% to 240.289 billion yuan, with the corporate loan NPL ratio decreasing to 0.95% [6]. Regulatory Issues - Qilu Bank faced significant regulatory penalties totaling 14.9513 million yuan for multiple violations in credit management, marking the largest penalty for a city commercial bank in 2024 [7][8]. - The penalties highlight weaknesses in internal control and compliance across various business lines [8]. Market Confidence - The bank has experienced significant shareholder reductions, with major shareholder Chongqing Huayu Group reducing its stake, raising concerns about market confidence [9][10]. - Despite a 51.35% increase in stock price from March 2024 to March 2025, the current price remains below its historical high of 11.66 yuan per share [10]. Future Outlook - Qilu Bank plans to implement a mid-year dividend policy, distributing a total of 1.286 billion yuan, which is 27.62% of its net profit for 2024, while focusing on strengthening core capital to address external challenges [11]. - The bank aims to balance growth and compliance, emphasizing the need to enhance retail business and internal controls to maintain its competitive edge in the regional banking sector [11].

Group 1 - Shareholder Guangzhou Yunmei Industrial Investment Partnership reduced holdings by 1,715,960 shares, accounting for 2% of the total share capital of Babwei Co., currently holding 5,426,897 shares, which is 6.33% [1] - Shareholders Yantai Tianzi Chunxue Equity Investment Center and Yantai Tianzi Xuerui Equity Investment Center plan to reduce holdings by up to 2,000,000 shares (1% of total share capital) and 4,000,000 shares (2% of total share capital) respectively for Chunxue Food [1] - Shareholder Ai Jianjie reduced holdings by 2,020,000 shares, accounting for 1.99% of the total share capital of Derui Lithium Battery, currently holding 13,265,738 shares, which is 13.0953% [1] Group 2 - Specific shareholder Zhao Dongmei plans to reduce holdings by up to 847,605 shares (1% of total share capital) for Haitai Technology [2] - Shareholder Wuxi Huahang Kechuang Investment Center plans to reduce holdings by up to 1,200,000 shares (0.46% of total share capital) for Hangya Technology [2] - Beijing Qianfang Technology Co., Ltd. plans to reduce holdings by up to 3,019,317 shares (3% of total share capital) for Hongquan Internet of Things [2] Group 3 - Shareholders Dongtai Huaju Enterprise Management Partnership and Dongtai Huahang Enterprise Management Consulting Partnership plan to reduce holdings by 2,695,188 shares (1.99% of total share capital) for Huashengchang [3] - Independent director Yan Wenfu plans to reduce holdings by up to 590 shares (0.0006% of total share capital) for Jianlong Micro-Nano [3] - Ningbo Jujie Junhe Venture Capital Partnership terminated a previous reduction plan, having reduced holdings by 1,286,300 shares (0.8621% of total share capital) for Jujie Microfiber [3] Group 4 - Shareholder Hunan Hualing Xiangtan Steel Co., Ltd. plans to reduce holdings by up to 39,188,754 shares (3% of total share capital) for Lanshi Heavy Industry [4] - Shareholders Wang Xiaojun and Quanzhou Lihu Zhizhen Investment Co., Ltd. plan to reduce holdings by up to 6,459,400 shares (3% of total share capital) for Lihu Co. [4] - Vice President Zhang Haolin did not execute the reduction plan, holding 84,500 shares (0.0908% of total share capital) for Ligong Optical Technology [4] Group 5 - Shareholder Zheng Zixian reduced holdings by 897,700 shares, currently holding 5,396,600 shares (4.9999% of total share capital) for United Precision [5] - Shareholder Li Da plans to reduce holdings by up to 4,223,539 shares (3% of total share capital) for Meinong Biological [5] - Shareholder Huai'an Zhongren Jiaye Venture Capital Partnership plans to reduce holdings by up to 197,450 shares (0.1499% of total share capital) for Nanling Technology [5] Group 6 - Shareholders Yang Jianping and Xu Huifen reduced holdings by 966,100 shares, currently holding 66,629,183 shares (19.999999% of total share capital) for Xuelang Environment [6] - Shareholder Anhui Zhidao Investment Co., Ltd. plans to reduce holdings by up to 1,830,384 shares (1% of total share capital) for Xueqi Electric [8] - Shareholder Fuzhou Shuihua Laoyou Enterprise Management Consulting Partnership reduced holdings by 1,371,448 shares (0.67% of total share capital) for Xunyout Technology [8]

截至2025年3月31日，前海股权基金为博盈特焊的第二大股东，深圳战兴基金为博盈特焊的第三大股 东。 博盈特焊于2023年7月24日在深交所创业板上市，首次公开发行股票数量3,300.00万股，发行价格47.58 元/股，保荐机构(主承销商)为中信建投（601066）证券股份有限公司，保荐代表人为李季刚、刘实。 上市首日，博盈特焊盘中创下最高价42.65元，为该股上市以来最高价。该股目前处于破发状态。 博盈特焊首次公开发行股票募集资金总额为157,014.00万元，扣除发行费用后募集资金净额为142,741.74 万元。博盈特焊最终募集资金净额比原计划多57741.74万元。博盈特焊于2023年7月14日发布的首次公 开发行股票并在创业板上市招股说明书显示，该公司拟募集资金85,000.00万元，用于防腐防磨产品研发 及生产基地建设项目、原厂区自动化升级改造项目、补充流动资金。 中国经济网北京4月28日讯博盈特焊（301468）(301468.SZ)近日发布公告称，公司收到持股5%以上股东 出具的《关于股份减持计划的告知函》。 前海股权投资基金(有限合伙)(以下简称"前海股权基金")是博盈特焊持股5%以上股东 ...

Core Points - Gannee Pharmaceutical recently disclosed a significant change in shareholder equity, with Beijing Xute Hongda Technology Co., Ltd. reducing its stake in the company [1][2] - The equity change period was from April 22, 2025, to April 24, 2025, during which Xute Hongda reduced its holdings by 849,822 shares, representing 0.14% of Gannee's total share capital [1][2] - After the change, Xute Hongda holds 40,634,035 shares, accounting for 6.76% of Gannee's total share capital, while its concerted actor, Gan Zhongru, holds 205,643,757 shares, representing 34.21% [1][2] Company Information - Gan Zhongru is the largest shareholder of Gannee Pharmaceutical, while Xute Hongda is the second largest shareholder [2] - Gan Zhongru has been the controlling shareholder and actual controller of Gannee since 2020, serving as the chairman of the company [2] - Gannee Pharmaceutical was listed on the Shanghai Stock Exchange on June 29, 2020, with an initial public offering (IPO) of 40.2 million shares at a price of 63.32 yuan per share [2][3] Fundraising Activities - Gannee Pharmaceutical raised a total of 2.545 billion yuan through its IPO, with a net amount of 2.441 billion yuan after expenses [2][3] - The funds raised were intended for various projects, including marketing network construction and the registration of insulin products in the U.S. [2] - In 2023, Gannee issued 28,508,550 shares at a price of 27.12 yuan per share, raising approximately 773.15 million yuan, with a net amount of about 759.73 million yuan after expenses [3]

减持目的与承诺履行 品渥食品近日发布一则股东减持计划预披露公告，持股5%以上股东吴柏赓计划在特定时间内减持公司 部分股份。这一举动引发市场关注，究竟是何原因促使股东减持，对公司又将产生何种影响？ 减持计划详情 截至公告披露日，吴柏赓持有品渥食品14,222,300股，占公司总股本比例14.37%（总股本按剔除公司回 购专用账户中的股份数量996,252股计算）。他计划在减持计划公告之日起15个交易日后的3个月内，即 2025年5月22日至2025年8月21日，通过集中竞价交易、大宗交易方式减持公司股份合计不超过2,970,111 股，即不超过公司总股本的3% 。 其中，通过集中竞价交易方式减持时，在任意连续90个自然日内减持股份的总数不超过公司股份总数的 1%。减持价格将根据减持时的二级市场价格及交易方式确定。若计划减持期间公司有送股、配股、资 本公积金转增股本等除权除息事项，减持数量将相应调整，减持比例保持不变。 虽然吴柏赓此次减持计划符合相关法律法规要求，但仍存在一定不确定性。他将根据市场情况、公司股 价情况等决定是否实施本次股份减持计划，减持时间、减持价格等实施细节存在变数。 从对公司影响来看，尽管公告 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：301428 证券简称：世纪恒通 公告编号：2025-024 世纪恒通科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经过审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ （二） 非经常性损益项目和金额 √适用 □不适用 单位：元 ■ 其他符合非经常性损益定义的损益项目的具体情况 √适用 □不适用 单位：元 ■ 将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性损益项目界 定为经常性损益项目的情况说明 □适用 √不适用 公司不存在将《公开发行证券的公司信息披露解释性公告第1号一一非经常 ...